4-MTA: A new synthetic drug on the dance scene

Drug and Alcohol Dependence

Volumn 67, Issue 2, 2002, Pages 111-115

  Winstock, Adam R ^a   Wolff, Kim ^a   Ramsey, John ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

'Flatliners'; 4 MTA; Clubbing; Dance drug; Recreational drug use

Indexed keywords

4 METHYLTHIOAMPHETAMINE; AMPHETAMINE DERIVATIVE; SEROTONIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AWARENESS; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG POTENCY; DRUG USE; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PERCEPTION; POPULATION; PRIORITY JOURNAL; SAMPLING; SEROTONIN RELEASE; SOCIAL DESIRABILITY;

ADOLESCENT; ADULT; AMPHETAMINES; DANCING; DATA COLLECTION; FEMALE; HUMANS; MALE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 0036644440     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(02)00018-2     Document Type: Article

References (32)

1. Use of drugs at 'Raves'
2. Another PMA-related fatality in Adelaide [letter]
3. Amphetamine derivative fatalities in South Australia - Is 'Ecstasy' the culprit?
4. Use of 'snowballing' technique to investigate subjective mood and personality traits associated with 'Ecstasy'
5. Metabolism of drugs of abuse by cytochromes P450
6. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; 'Ecstasy')
7. Mood and cognitive effects of +/- 3,4 methylene dioxymethamphetamine (MDMA, 'ecstasy'): Weekend high followed by mid Week low
8. MDMA induced hyperthermia: A report of a fatality and review of current therapy
9. Muscial preference as an indicator of adolescent drug use
10. Fatal uncertainty: Death-rate from the use of ecstasy or heroin
11. Drug information systems, early warning, and new drug trends: Can drug monitoring systems become more sensitive to emerging trends in drug consumption?
12. The identification of 4-methylthioamphetamine in a drug seizure
13. P-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent
14. Selective serotonin reuptake inhibitor-induced serotonin syndrome
15. Neuroendocrine pharmacology of three serotonin releasers: 1(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl2-aminoindan (MMAi) and p-methylthioamphetamine (MTA)
16. Pathology of deaths associated with 'ecstasy' and 'eve' misuse
17. Sulfur analogs of psychotomimetic amines
18. Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: A validity study
19. The identification of 4-methylthioamphetamine
20. Ecstasy use in Australia: Patterns of use and associated harm
21. Adverse effects of stimulant users in a community sample of drug users
22. Tablets often contain substances in addition to, or instead of Ecstasy
23. Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK
24. Ecstasy pill testing: Harm minimization Gone too far?
25. Contents of ecstasy